Skip to content

Psychedelic Therapy

Harish Naraindas

The Movement for Global Mental Health 2021 DOI: 10.5117/9789463721622_ch06 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Ethnography Peer reviewed
Population A psychosomatic department in a German hospital
Topics Psychedelic-assisted therapy
Key findings The global mental health movement's preoccupation with the Global South and its reliance on psycho-pharmaceuticals contrast with German psychosomatic medicine, which avoids such drugs and does not sharply separate superstition from science.

Abstract

This chapter, which is an ethnography of a psychosomatic department in a German hospital, functions as a foil to the rest of the volume. It allows us to ask the following: Why is the movement for global mental health preoccupied with the Global South? Why does mental health in the Global South primarily revolve around the psycho-pharmaceutical, while psychosomatic medicine, which in the German context is a separate discipline divorced from psychiatry, is normatively built on eschewing psycho-pharmaceuticals? Why is mental health in the Global South built on the distinction between superstition (past lives, trance, possession – in short, ‘rituals’ invoking the spirits and the dead) and science (psychiatry, rational diagnosis, asylums, drugs), while in Germany the two are often fused?

Comparable studies

Other qualitative studies on psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression enrolled in an open-label trial of psilocybin 2017 Qualitative study n = 20
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Patients with anxiety associated with life-threatening diseases 2014 Prospective follow-up with qualitative content analysis n = 10
Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis Adults aged 22 to 69 with clinically elevated anxiety associated with a cancer diagnosis 2017 Qualitative study n = 13
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts Participants who completed a psilocybin-facilitated smoking cessation pilot study 2018 Qualitative follow-up study using semi-structured interviews and thematic analysis n = 12
The hidden therapist: evidence for a central role of music in psychedelic therapy Patients undergoing psychedelic therapy with psilocybin for treatment-resistant depression 2018 Qualitative study n = 19

Explore topics